A5049687972- Diabetes Treatment and Management
- Chronic Kidney Disease and Diabetes
- Diabetes Management and Research
- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Dialysis and Renal Disease Management
- Chronic Disease Management Strategies
- Healthcare Policy and Management
- Spondyloarthritis Studies and Treatments
- Medicinal Plants and Bioactive Compounds
- Complementary and Alternative Medicine Studies
- Global Public Health Policies and Epidemiology
- Healthcare Systems and Reforms
- Pharmacology and Obesity Treatment
- Renal and Vascular Pathologies
- Therapeutic Uses of Natural Elements
- Acute Ischemic Stroke Management
- Treatment of Major Depression
- Cardiovascular Syncope and Autonomic Disorders
- Autoimmune and Inflammatory Disorders Research
- Diet and metabolism studies
- Clinical practice guidelines implementation
- Cerebrovascular and Carotid Artery Diseases
- Acupuncture Treatment Research Studies
- Diabetes Management and Education
Bayer (United States)
2020-2024
Jawaharlal Institute of Post Graduate Medical Education and Research
2024
Medical College and Hospital, Kolkata
2023
Bayer (Germany)
2022
Tufts Medical Center
2021
AbbVie (United States)
2017-2020
AbbVie (Japan)
2020
Abbott (Sweden)
2017
Importance Albuminuria testing is crucial for guiding evidence-based treatments to mitigate chronic kidney disease (CKD) progression and cardiovascular morbidity, but it widely underutilized among persons with or at risk CKD. Objective To estimate the extent of albuminuria underdetection from lack evaluate its association CKD treatment in a large US cohort patients hypertension diabetes. Design, Setting, Participants This study examined adults diabetes, using data 2007 2018 National Health...
Abstract Aim Guideline‐directed medical therapy (GDMT) is designed to improve clinical outcomes. The study aim was assess GDMT prescribing rates and prescribing‐persistence predictors in patients with diabetes chronic kidney disease (CKD) from the Center for Kidney Disease Research, Education, Hope Registry. Materials Methods Data were obtained adults ≥18 years old CKD between 1 January 2019 31 December 2020 (N = 39 158). Baseline persistent (≥90 days) prescriptions GDMT, including...
The prevalence of chronic kidney disease (CKD) in adults ≥18 years age with type 1 diabetes the U.S. was determined using National Health and Nutrition Examination Survey (NHANES) data.
To assess the prevalence and correlates of prescription sodium-glucose cotransporter 2 inhibitors (SGLT2i) and/or glucagon-like peptide 1 receptor agonists (GLP1-RA) in individuals with type diabetes mellitus (T2DM) without chronic kidney disease (CKD).This was a cross-sectional analyses SGLT2i GLP1-RA prescriptions from January 2019 to 31 December 2020 Veterans Health Administration System. The likelihood examined by presence or absence CKD predicted risks atherosclerotic cardiovascular...
Predictive risk models identifying patients at high for specific outcomes may provide valuable insights to providers and payers regarding points of intervention modifiable factors. The goal our study was build predictive identify with chronic kidney disease (CKD) type 2 diabetes (T2D) progression end stage (ESKD), mortality, hospitalization cardiovascular (CVD), cerebrovascular (CeVD), heart failure (HF).This a retrospective observational cohort utilizing administrative claims data in CKD...
This brief report utilizes EHR data from a large US health system to summarize unmet needs in patients with type 2 diabetes and chronic kidney disease identifies areas of opportunity optimize management within this patient population treatment, screening monitoring, care resource use perspectives.
We describe the substantial shortfall in adherence to guideline-recommended albumin-to-creatinine ratio (uACR) testing for people United States with type 2 diabetes. Poor compliance current guidelines leads delays diagnosis-and treatment- of chronic kidney disease, which adversely affects clinical outcomes and contributes incremental economic burden.
Regional variation in chronic kidney disease (CKD) prevalence patients with or without type 2 diabetes mellitus (T2DM) has not been well characterized.Spatial and temporal comparative analysis.MarketScan databases were used to identify CKD overall subgroups of T2DM the United States.Spatial patterns based on year, regional clusters between years, characteristics high-prevalence states.Geomapping was visualize state-level data generated from 2013 2018. We univariate local indicators spatial...
BACKGROUND: Chronic kidney disease (CKD) is a major public health concern that affects 37 million adults in the United States. It well known CKD presents large economic burden, especially Medicare population. However, studies of burden younger populations are scarce. In particular, there gap understanding how presence type 2 diabetes mellitus (T2DM) commercially insured populations. OBJECTIVE: To describe and care resource utilization (HCRU) within 3 patient groups (T2DM only, T2DM) aged...
Chronic obstructive pulmonary disease (COPD) patients often experience acute exacerbations requiring hospitalization. Recently, attention has focused on Aspergillus sensitization in the airways of these COPD patients. This study aimed to assess prevalence chronic aspergillosis (CPA) with and identify associated risk factors. A cross-sectional descriptive was conducted at Jawaharlal Institute Postgraduate Medical Education Research from January 2021 June 2022. Sixty-one presenting were...
Patients with psoriatic arthritis (PsA) who receive an initial tumor necrosis factor inhibitor (TNFi) may switch to another TNFi or a non-TNFi biologic therapy. This study compared the healthcare resource use (HRU), expenditures, and time discontinuation among TNFi-experienced patients PsA switched different therapies in United States (US). Adults discontinued (adalimumab, etanercept, infliximab, golimumab, certolizumab pegol) (ustekinumab secukinumab) were identified Symphony Health...
<b><i>Introduction:</i></b> The coronavirus disease 2019 (COVID-19) is leading to unknown and unusual health conditions that are challenging manage. Post-COVID-19 fatigue one of those challenges, becoming increasingly common as the pandemic evolves, it impairs quality life an individual. This trial attempts identify preliminary evidence efficacy individualized homeopathic medicines (IHMs) against placebos in treatment post-COVID-19 adults....
Clinical practice guidelines recommend at least annual testing of estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) for patients with chronic kidney disease (CKD) type 2 diabetes (T2D). This study assessed the adequacy eGFR uACR in this patient population across United States.Observational real-world study.Adults CKD T2D were identified from Optum Clinformatics database (2015-2019). The tests nationally by state. proportions tested receiving adequate...
This article explores the relationship between mental health outcomes and social determinants of among immigrant populations. By analyzing survey data, research identifies key factors such as socioeconomic status, access to healthcare, support that influence health. The findings suggest addressing is essential for improving providing effective services immigrants.
<title>Abstract</title> Social drivers of health (SDOH) can impact access to routine care, including annual screening for chronic kidney disease (CKD). Clinical practice guidelines recommend regular after diagnosis hypertension (HTN) or type 2 diabetes (T2DM). We explore how SDOH are associated with CKD and development among newly diagnosed HTN and/or T2DM patients. Electronic records 235,208 patients a new between 2015–2018 were extracted followed three years assess development....